These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1057698)

  • 21. Molecules in the middle molecular weight range. Critical review of methods of separation from fluids of uremic patients.
    Contreras P; Later R; Navarro J; Touraine JL; Freyria AM; Traeger J
    Nephron; 1982; 32(3):193-201. PubMed ID: 6759948
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 23. [Exchangeable sodium, fluid space and hypertonia in chronic uremia].
    Vorburger C; Hodler J; Reubi F
    Helv Med Acta Suppl; 1969; 49():178. PubMed ID: 5267574
    [No Abstract]   [Full Text] [Related]  

  • 24. An overview of clinical implications of middle molecules and their kinetics in uremia.
    Funck-Brentano JL; Man NK
    Artif Organs; 1981; 4 Suppl():125-32. PubMed ID: 7295078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation and quantification of the "middle molecules" in uremia.
    Chapman GV; Ward RA; Farrell PC
    Kidney Int; 1980 Jan; 17(1):82-8. PubMed ID: 7374022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What causes toxicity in uraemia?
    Br Med J; 1977 Jul; 2(6080):143-4. PubMed ID: 871815
    [No Abstract]   [Full Text] [Related]  

  • 27. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U; Pilone N; Cioni L; Ronca G
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Distribution of low- and medium-molecular-weight substances in biological fluids of healthy children].
    Gorbatova LN; Bebiakova NA; Sumarokova AV
    Fiziol Cheloveka; 2007; 33(1):114-8. PubMed ID: 17361616
    [No Abstract]   [Full Text] [Related]  

  • 29. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The elusive middle molecule?
    Hattler BG
    Proc Clin Dial Transplant Forum; 1973; 3():130-4. PubMed ID: 4283132
    [No Abstract]   [Full Text] [Related]  

  • 31. Uraemic toxins.
    Dawborn JK
    Aust N Z J Med; 1981; 11(Suppl 1):40-5. PubMed ID: 6942801
    [No Abstract]   [Full Text] [Related]  

  • 32. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 33. Technical aspects on middle molecules: separation, isolation, and identification.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Middle molecules--a marker of endogenous intoxication (a review of the literature)].
    Parfenkova GA; Cherniad'eva IF; Sitina VK
    Vrach Delo; 1987 Apr; (4):72-7. PubMed ID: 3303687
    [No Abstract]   [Full Text] [Related]  

  • 36. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for separation of middle molecules by high performance liquid chromatography: application in studies of glucuronyl-o-hydroxyhippurate in normal and uremic subjects.
    Zimmerman L; Bergström J; Jörnvall H
    Clin Nephrol; 1986 Feb; 25(2):94-100. PubMed ID: 3698350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medium molecules in uremia. Isolation techniques, chemical determination, biological tests, and the effects of dialysis].
    Buzio C; Manari A; Montagna G; Arisi L; Calderini C; Savazzi G; Migone L
    Minerva Nefrol; 1980; 27(3):483-94. PubMed ID: 7231798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.